SCHEMBL5587536

SCHEMBL5587536

CCOc1c(O)c(C(=O)O)c(F)c(F)c1F

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.37
METAP2 P50579 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
PKM P14618 1/20 0.36
MAPT P10636 2/20 0.34
POLB P06746 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TSHR P16473 5/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CYP2C9 P11712 2/20 0.33
THRB P10828 1/20 0.33
CYP1A2 P05177 1/20 0.33
GFER P55789 1/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
HSD17B10 Q99714 1/20 0.31
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5586791 0.86 ESR1 (0.41) ESR1METAP2SMN1; SMN2PKMMAPT
SCHEMBL27830419 0.85 THRB (0.41) ESR1METAP2SMN1; SMN2PKMMAPT
SCHEMBL5590011 0.83 ESR1 (0.50) ESR1TSHRTHRB
SCHEMBL8464048 0.83 METAP2 (0.39) ESR1METAP2SMN1; SMN2PKMMAPT
SCHEMBL5588827 0.82 ESR1 (0.45) ESR1TDP1TSHRMEN1KMT2A
SCHEMBL5587125 0.81 PLA2G2A (0.44) ESR1TDP1TSHRMEN1KMT2A
SCHEMBL5590200 0.81 PLA2G2A (0.44) ESR1TDP1TSHRMEN1KMT2A
SCHEMBL5590470 0.81 PLA2G2A (0.44) ESR1TDP1TSHRMEN1KMT2A
SCHEMBL5590250 0.81 PLA2G2A (0.44) ESR1TDP1TSHRMEN1KMT2A
SCHEMBL5588560 0.81 PLA2G2A (0.44) ESR1TDP1TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ESR1 1108/4885METAP2 3428/4885SMN1; SMN2 3076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.